00947A: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma

Grant Status: Closed

Grant Amount: $147,482.64
Dr. Matthew Breen, PhD, North Carolina State University
August 1, 2008 - November 30, 2011
Breed(s): Rottweiler, Golden Retriever
Research Program Area: Prevention

Project Summary

In this study we recruited 140 cases of canine osteosarcoma, representing client owned dogs of various breeds. Of these, 123 cases were analyzed using genome-wide 1Mb spacing BAC array comparative genomic hybridization (aCGH) to reveal changes in DNA copy number that were recurrent in canine osteosarcoma. This study represents that largest single cohort of osteosarcoma patients evaluated using aCGH, including human studies. Our data showed that, as with human osteosarcoma, canine osteosarcoma typically presents with chaotic copy number profiles, comprising whole chromosome aneuploidy, single locus copy number aberrations and structural rearrangements. Overall, chromosomal regions were more likely to experience copy number gain than copy number loss; within the sample population seven chromosomes contained regions that experienced greater than 10% copy number loss, while 23 chromosomes experienced regions with a copy number gain frequency greater than 10%. Dog chromosome 23 appeared to be the least aberrant chromosome with little variation between patients. The majority of regions experiencing >10% aberration frequency of copy number change in canine OS were <5Mb in size, while regions with < 5% aberration frequency were generally larger in size. These finding were published in the Sept 2011 issue of Journal 'Genes, Chromosomes and Cancer'. Subsequent to that component of the study, we analyzed 23 of the canine cases using a CGH platform with considerably higher resolution. This new array comprised 180,000 probes (compared to the 2,100 probes on the earlier version) that provided 76 times the amount of data. Analysis of these 23 canine osteosarcoma cases concluded that a pattern of high genomic instability is maintained when increasing genomic resolution. As expected, the higher resolution analysis, however, identified several micro-regions (<500kb) of copy number changes that were shown to be comparable to what we observed in our parallel study of human osteosarcoma. Comparison of canine and human osteosarcoma aCGH data identified that the most frequent regional copy number gains and losses in our dog and human cases were shared, with remarkably similar frequencies. The incidence of these aberrations in both in human and dog OS suggest that these specific genes may be directly contributing to the cancer phenotype. Nine genes of interest were analyzed for altered expression levels; MYC, MEN1, CDKN2A/B, TERT, PTEN, RHOC, RUNX2, TSC2 and TUSC3. From a comparative perspective these genes have now been implicated to be associated with human osteosarcoma. Functional analysis of these genes identified several cellular pathways deregulated in osteosarcoma. A manuscript reporting the finding of our high resolution, comparative assessment of canine and human osteosarcoma is in the final stages of preparation and is scheduled for submission in early 2012. It is very clear from the data generated in thus study that human and dog OS share conserved DNA copy number aberrations. We identified that orthologous regions in humans and canines have similar types (gain and loss) and frequencies of aberrations in osteosarcoma. These data strongly support the conserved nature of osteosarcoma. These data are now being used to advance new areas of research that ultimately we hope will lead to improved therapies for our canine patients, and maybe even our human patients.

Publication(s)

- Venugopal Thayanithy, Aaron L. Sarver, Reena V. Kartha, ChangWon Park, Milcah Scott, Andrea C. Young, Matthew Breen, Clifford J. Steer, Jaime F. Modiano and Subbaya Subramanian (2011). Perturbation in 14q32 miRNAs-MYC-miR-17~92 gene network contributes

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $40
  • $60
  • $100
  • $250
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2015 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software